The Mentzer Index in Maternal Anemia: An Early Diagnostic Marker

Maternal anemia is a prevalent condition that poses significant health risks to both mothers and their infants. Accurate and timely diagnosis is crucial for effective management, particularly in differentiating between iron deficiency anemia (IDA) and thalassemia trait (TT), two common causes of microcytic anemia during pregnancy. The Mentzer Index (MI), a simple and cost-effective diagnostic tool, is used to distinguish between these two conditions by calculating the ratio of mean corpuscular volume (MCV) to red blood cell (RBC) count. This review explores the utility of the Mentzer Index in maternal anemia diagnosis, highlighting its role in early detection and management. The Mentzer Index offers a rapid, straightforward approach to identifying the underlying cause of anemia in pregnant women, especially in resource-limited settings. A result of MI < 13 suggests thalassemia trait, while MI > 13 is indicative of iron deficiency anemia. Early differentiation allows for targeted interventions, such as iron supplementation for IDA, and avoids unnecessary iron therapy in TT, thus optimizing patient outcomes. Despite its advantages, the MI has limitations, particularly in cases of mixed anemia or when other forms of anemia are present. In such instances, further diagnostic tests are necessary for an accurate diagnosis. Keywords: Mentzer Index, Maternal Anemia, Iron Deficiency, Thalassemia, Early Diagnosis